Image 1
Trospium Chloride Capsule, Extended Release
Product Images NDC 0591-3636
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Trospium Chloride (NDC 0591-3636). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Image 3
Image 4
Image 5
Image 6
Image 7
This is a description of Actavis brand trospium chloride extended-release capsules in its container dispensed by a pharmacist. Each capsule contains 0.60mg of trospium chloride for use by patients as directed by a physician. These capsules should be kept out of reach of children and stored at room temperature. Manufacturing is done in Fort Lauderdale, FL, and distribution by Actavis Pharma, Inc., in Parsippany, NJ.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
